 TORONTO--BUSINESS WIRE--- HUGE--FSD Pharma Inc. Nasdaq:HUGE CSE:HUGE the Company or FSD Pharma is pleased to announce the appointment of Nathan Coyle, the Companys Corporate Controller as its Interim Chief Financial Officer, following the departure of Donal Carroll, effective immediately. Mr. Coyle joined FSD Pharma Inc in 2020 as Corporate Controller and has 15 years of executive business experience as a finance leader in both public and private roles. Mr. Coyle was previously with Illino 